3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma, Kaposi
1
Acquired Immunodeficiency Syndrome
1
Interventions
Ritonavir
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
dolutegravir
1
Papillomavirus Vaccines
1
Nucleosides
1
Nevirapine
1
Lopinavir
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
Emtricitabine
1
Darunavir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Acquired Immunodeficiency Syndrome
×
Nevirapine
×
Clear all
NCT00380770
2010-07-21
KAART
University of KwaZulu
Phase 4
Completed
112 enrolled